Farther Finance Advisors LLC Has $126,000 Position in Pulse Biosciences, Inc. (NASDAQ:PLSE)

Farther Finance Advisors LLC increased its stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) by 44.4% in the 4th quarter, Holdings Channel reports. The firm owned 7,220 shares of the company’s stock after purchasing an additional 2,220 shares during the period. Farther Finance Advisors LLC’s holdings in Pulse Biosciences were worth $126,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. lifted its holdings in Pulse Biosciences by 0.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 149,206 shares of the company’s stock worth $2,598,000 after purchasing an additional 1,092 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Pulse Biosciences in the 4th quarter worth approximately $193,000. Bender Robert & Associates acquired a new stake in Pulse Biosciences in the 4th quarter worth approximately $202,000. Oppenheimer & Co. Inc. acquired a new stake in Pulse Biosciences in the 4th quarter worth approximately $311,000. Finally, Franklin Resources Inc. acquired a new stake in Pulse Biosciences in the 3rd quarter worth approximately $378,000. 76.95% of the stock is currently owned by institutional investors and hedge funds.

Pulse Biosciences Stock Down 3.3 %

Shares of NASDAQ PLSE opened at $16.21 on Friday. The business’s 50 day moving average is $19.03 and its two-hundred day moving average is $18.22. Pulse Biosciences, Inc. has a 12 month low of $6.60 and a 12 month high of $25.00.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a research report on Thursday, January 2nd.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.